Explore how EGFR and KRAS G12C biomarkers reshape lung cancer care, from first-line choices to resistance, testing, and prognosis.
Misty D. Shields, MD, PhD
Advertisement
Articles by Misty D. Shields, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
5 Things to Know About the One Big Beautiful Bill Act
2
PBM Reform and Supportive Care Needs: Nicolas Ferreyros
3
Coroner Reports Pennsylvania's Sixth Measles-Associated Death
4
Genetic Analysis Links Insomnia Liability to Higher Inflammation Marker
5